September 11, 2023, the U.S. Food and Drug Administration announced1 it had approved reformulated monovalent COVID shots by Pfizer and Moderna for use in individuals 12 years of age and older. They also issued emergency use authorization (EUA) for use of the reformulated jabs in children aged 6 months to 11 years.2 The updated mRNA… Read More »
Despite a century of research, American medicine offers as little today for the prevention and treatment of eclampsia traditionally called toxemia as it did a hundred years ago. This progressive and potentially fatal condition remains a leading cause of miscarriage, premature birth, and infant mortality in the United States and around the world. An estimated… Read More »
The Federal Communications Commission this week opened enrollment for its Emergency Broadband Benefit program, aimed at expanding connectivity to people in need via discounted internet services. Those eligible for the program include people who experienced a substantial loss of income in 2020; individuals who currently receive or qualify for Lifeline benefits through federal programs… Read More »